Log in to save to my catalogue

Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease

Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1665119840

Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease

About this item

Full title

Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2015-03, Vol.372 (12), p.1104-1113

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

The chronic inflammation of Crohn's disease is caused, at least in part, by repression of TGF-β1 signaling, which is caused by high levels of SMAD7. This trial shows that mongersen, an antisense inhibitor of
SMAD7
mRNA, induces disease remission in some persons.
Crohn’s disease is a chronic inflammatory illness that primarily affects the t...

Alternative Titles

Full title

Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1665119840

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1665119840

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1407250

How to access this item